Status: Recruiting
Safety and Tolerability of IMM01-STEM in Patients With Muscle Atrophy Related to Knee Osteoarthritis.
An open-label dose escalation study to assess the safety and tolerability of IMM01-STEM in participants with muscle atrophy related to knee osteoarthritis
Participants needed: 28
Trial details
Phase: Phase 1, Phase 2Age: 50-75Biological sex: AllType: InterventionalSponsor: Immunis, Inc.Updated: Oct 30, 2025Locations: 2
Eligibility criteria
Has moderate KOA (defined as Kellgren-Lawrence [KL] grade 2 to 3) on affected li... [+14]
Severe KOA (defined as KL grade >3) on contralateral limb [+17]